Veeva Systems (VEEV) Expected to Announce Earnings on Wednesday

Veeva Systems (NYSE:VEEVGet Free Report) is expected to release its Q2 2026 results after the market closes on Wednesday, August 27th. Analysts expect Veeva Systems to post earnings of $1.90 per share and revenue of $768.4940 million for the quarter. Parties may visit the the company’s upcoming Q2 2026 earningresults page for the latest details on the call scheduled for Wednesday, August 27, 2025 at 5:00 PM ET.

Veeva Systems (NYSE:VEEVGet Free Report) last announced its quarterly earnings data on Wednesday, May 28th. The technology company reported $1.97 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.74 by $0.23. The firm had revenue of $759.04 million during the quarter, compared to the consensus estimate of $728.38 million. Veeva Systems had a return on equity of 13.96% and a net margin of 27.34%.The business’s revenue for the quarter was up 16.7% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.50 EPS. On average, analysts expect Veeva Systems to post $4 EPS for the current fiscal year and $5 EPS for the next fiscal year.

Veeva Systems Price Performance

Shares of NYSE:VEEV opened at $283.9690 on Wednesday. The company has a market capitalization of $46.40 billion, a PE ratio of 60.16, a price-to-earnings-growth ratio of 2.23 and a beta of 0.95. The business has a fifty day moving average price of $282.25 and a two-hundred day moving average price of $251.54. Veeva Systems has a 1 year low of $192.73 and a 1 year high of $296.72.

Insider Transactions at Veeva Systems

In other news, SVP Jonathan Faddis sold 720 shares of Veeva Systems stock in a transaction that occurred on Thursday, July 10th. The stock was sold at an average price of $285.62, for a total value of $205,646.40. Following the sale, the senior vice president directly owned 7,902 shares in the company, valued at approximately $2,256,969.24. This trade represents a 8.35% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Timothy S. Cabral sold 315 shares of Veeva Systems stock in a transaction that occurred on Friday, June 6th. The stock was sold at an average price of $289.72, for a total value of $91,261.80. Following the completion of the sale, the director owned 5,500 shares in the company, valued at approximately $1,593,460. This represents a 5.42% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 1,378 shares of company stock worth $394,217. 10.30% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Veeva Systems

Several hedge funds have recently added to or reduced their stakes in the stock. Bank of America Corp DE boosted its holdings in Veeva Systems by 3.9% in the second quarter. Bank of America Corp DE now owns 1,274,735 shares of the technology company’s stock worth $367,098,000 after acquiring an additional 47,550 shares in the last quarter. Durable Capital Partners LP bought a new stake in Veeva Systems in the second quarter worth $281,351,000. Raymond James Financial Inc. raised its stake in shares of Veeva Systems by 1.0% in the second quarter. Raymond James Financial Inc. now owns 420,236 shares of the technology company’s stock worth $121,020,000 after purchasing an additional 4,192 shares during the last quarter. Corient Private Wealth LLC raised its stake in shares of Veeva Systems by 91.9% in the second quarter. Corient Private Wealth LLC now owns 325,553 shares of the technology company’s stock worth $93,753,000 after purchasing an additional 155,916 shares during the last quarter. Finally, Worldquant Millennium Advisors LLC raised its stake in shares of Veeva Systems by 532.5% in the second quarter. Worldquant Millennium Advisors LLC now owns 311,031 shares of the technology company’s stock worth $89,571,000 after purchasing an additional 261,857 shares during the last quarter. 88.20% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

VEEV has been the topic of a number of recent research reports. Mizuho increased their price objective on Veeva Systems from $280.00 to $295.00 and gave the stock an “outperform” rating in a report on Monday, June 2nd. Truist Financial raised their price target on Veeva Systems from $217.00 to $230.00 and gave the company a “hold” rating in a report on Thursday, May 29th. Morgan Stanley raised their price objective on Veeva Systems from $201.00 to $210.00 and gave the company an “underweight” rating in a report on Thursday, May 29th. Raymond James Financial raised their price objective on Veeva Systems from $285.00 to $310.00 and gave the company an “outperform” rating in a report on Thursday, May 29th. Finally, UBS Group raised their price objective on Veeva Systems from $250.00 to $285.00 and gave the company a “neutral” rating in a report on Thursday, May 29th. Fourteen equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Veeva Systems currently has a consensus rating of “Moderate Buy” and an average price target of $274.17.

View Our Latest Analysis on VEEV

Veeva Systems Company Profile

(Get Free Report)

Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.

Read More

Earnings History for Veeva Systems (NYSE:VEEV)

Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.